珞安科技连续完成1亿元B+、B++两轮战略融资
更多 2021-08-13
恒旭资本领投励楷科技B轮融资
更多 2021-08-12
昌郁医药镇痛产品XG005获得一类创新药临床试验许可
更多 2021-08-11
天瞳威视完成1.5亿美元C轮融资,计划2022年启动IPO
更多 2021-07-26
恒旭资本领投新瑞立A轮融资
更多 2021-07-05
映驰科技完成近亿元人民币A轮融资
更多 2021-06-25
芯旺微电子入选2020中国IC独角兽企业
更多 2021-06-21
高诚生物完成7500万美元D轮融资,用于加速创新管线品种推进
更多 2021-06-17
UTC完成6000多万美元A+轮融资 用于开发细胞治疗药物
更多 2021-06-15
迪凯尔医疗完成近亿元C轮融资,恒旭资本领投
更多 2021-06-10
Top

Change of Address Notice


Dear investors and partners,


With your ongoing care and support, Hengxu Capital has achieved significant development and progress since its establishment. In order to better meet the needs of our business operations, our office location will be relocated to 5F, Building N3, New Bund Square City, No. 2, Lane 131, Qiantan Avenue, Pudong New District, Shanghai(Map Link: https://j.map.baidu.com/b5/x7VK).


The new office space is conveniently located with excellent facilities, providing improved conditions for meetings, receptions, and work. This relocation will facilitate better communication and collaboration between Hengxu Capital and our partners, enhancing employee satisfaction and office efficiency, and laying a solid foundation for continued and rapid business development.



The new office has been officially in use since January 29, and our mailing address has been switched to the new location. Considering the approaching Chinese New Year, we will not hold a relocation ceremony at the moment but plan to invite you to visit and guide us at a suitable time in the future.


If you have any questions or concerns, please feel free to contact us. Our phone numbers and email addresses remain unchanged. Once again, we appreciate your support and understanding, and we look forward to creating a brighter future together.


Shanghai SAIC Hengxu Capital Co., Ltd.


Jan. 29, 2024